Cargando...
Immune checkpoint inhibitor‐induced Type 1 diabetes: a systematic review and meta‐analysis
AIM: To conduct a systematic review and meta‐analysis to understand the timing and factors associated with anti‐programmed cell death protein‐1 (PD‐1)/anti‐programmed cell death protein‐1 ligand (PD‐L1) inhibitor‐induced Type 1 diabetes. METHODS: We searched MEDLINE, EMBASE, SCOPUS and Cochrane data...
Guardado en:
| Publicado en: | Diabet Med |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6698212/ https://ncbi.nlm.nih.gov/pubmed/31199005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.14050 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|